225 related articles for article (PubMed ID: 28710117)
21. Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids.
Dreijerink KM; Derks JL; Cataldo I; Scarpa A; Valk GD; Speel EJ
Front Horm Res; 2015; 44():115-38. PubMed ID: 26303708
[TBL] [Abstract][Full Text] [Related]
22. Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?
Delgado Verdugo A; Crona J; Maharjan R; Hellman P; Westin G; Björklund P
Horm Metab Res; 2015 Jun; 47(6):452-5. PubMed ID: 25354328
[TBL] [Abstract][Full Text] [Related]
23. Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system.
Arnold CN; Sosnowski A; Schmitt-Gräff A; Arnold R; Blum HE
Int J Cancer; 2007 May; 120(10):2157-64. PubMed ID: 17278096
[TBL] [Abstract][Full Text] [Related]
24. Genomic Aberrations Drive Clonal Evolution of Neuroendocrine Tumors.
Kaushik AK; Sreekumar A
Trends Endocrinol Metab; 2016 May; 27(5):242-244. PubMed ID: 27037211
[TBL] [Abstract][Full Text] [Related]
25. Future Directions in the Biology of Neuroendocrine Tumors.
Halperin DM; Dasari A; Yao JC
Pancreas; 2016 Jul; 45(6):783-5. PubMed ID: 27295529
[TBL] [Abstract][Full Text] [Related]
26. Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.
Vollbrecht C; Werner R; Walter RF; Christoph DC; Heukamp LC; Peifer M; Hirsch B; Burbat L; Mairinger T; Schmid KW; Wohlschlaeger J; Mairinger FD
Br J Cancer; 2015 Dec; 113(12):1704-11. PubMed ID: 26645239
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.
Ohmoto A; Rokutan H; Yachida S
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098761
[TBL] [Abstract][Full Text] [Related]
28. Serotonin, ATRX, and DAXX Expression in Pituitary Adenomas: Markers in the Differential Diagnosis of Neuroendocrine Tumors of the Sellar Region.
Casar-Borota O; Botling J; Granberg D; Stigare J; Wikström J; Boldt HB; Kristensen BW; Pontén F; Trouillas J
Am J Surg Pathol; 2017 Sep; 41(9):1238-1246. PubMed ID: 28719461
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression.
Di Domenico A; Pipinikas CP; Maire RS; Bräutigam K; Simillion C; Dettmer MS; Vassella E; Thirlwell C; Perren A; Marinoni I
Commun Biol; 2020 Dec; 3(1):740. PubMed ID: 33288854
[TBL] [Abstract][Full Text] [Related]
30. Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets.
Capdevila J; Meeker A; García-Carbonero R; Pietras K; Astudillo A; Casanovas O; Scarpa A
Cancer Metastasis Rev; 2014 Mar; 33(1):345-51. PubMed ID: 24375391
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.
How-Kit A; Dejeux E; Dousset B; Renault V; Baudry M; Terris B; Tost J
Epigenomics; 2015; 7(8):1245-58. PubMed ID: 26360914
[TBL] [Abstract][Full Text] [Related]
32. Epigenetics in lung cancer diagnosis and therapy.
Mehta A; Dobersch S; Romero-Olmedo AJ; Barreto G
Cancer Metastasis Rev; 2015 Jun; 34(2):229-41. PubMed ID: 25939322
[TBL] [Abstract][Full Text] [Related]
33. Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis.
Hackeng WM; Brosens LA; Poruk KE; Noë M; Hosoda W; Poling JS; Rizzo A; Campbell-Thompson M; Atkinson MA; Konukiewitz B; Klöppel G; Heaphy CM; Meeker AK; Wood LD
Hum Pathol; 2016 Oct; 56():93-100. PubMed ID: 27342911
[TBL] [Abstract][Full Text] [Related]
34. Rethinking pheochromocytomas and paragangliomas from a genomic perspective.
Castro-Vega LJ; Lepoutre-Lussey C; Gimenez-Roqueplo AP; Favier J
Oncogene; 2016 Mar; 35(9):1080-9. PubMed ID: 26028031
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathology and genetics of gastrointestinal neuroendocrine tumours.
Lewis MA; Yao JC
Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):22-7. PubMed ID: 24310147
[TBL] [Abstract][Full Text] [Related]
36. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report.
Neychev V; Sadowski SM; Zhu J; Allgaeuer M; Kilian K; Meltzer P; Kebebew E
J Clin Endocrinol Metab; 2016 Feb; 101(2):353-8. PubMed ID: 26678657
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic significance of immunostaining of α-thalassemia/mental retardation syndrome X-linked protein and death domain-associated protein in neuroendocrine tumors.
Chen SF; Kasajima A; Yazdani S; Chan MS; Wang L; He YY; Gao HW; Sasano H
Hum Pathol; 2013 Oct; 44(10):2199-203. PubMed ID: 23954140
[TBL] [Abstract][Full Text] [Related]
39. Tumour biology of gastroenteropancreatic neuroendocrine tumours.
Grötzinger C
Neuroendocrinology; 2004; 80 Suppl 1():8-11. PubMed ID: 15477708
[TBL] [Abstract][Full Text] [Related]
40. Disruption of the epigenetic code: an emerging mechanism in mental retardation.
van Bokhoven H; Kramer JM
Neurobiol Dis; 2010 Jul; 39(1):3-12. PubMed ID: 20304068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
